S&P forecasts a revenue decline of 8% in 2025, with the EBITDA margin dropping to 14% from 15.3% in 2024, due to lower rig ...

Although prudent on the surface, Altria's attempts to diversify from cigarettes have fallen flat. Its $1.8 billion investment into Canada cannabis licensed producer Cronos for a 41% stake and a $12.8 ...